August 23, 2017 12:14 AM ET

Pharmaceuticals

Company Overview of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd

Company Overview

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd manufactures and sells heparin sodium and low molecular weight heparin products for pharmaceutical companies in the People’s Republic of China. It offers enoxaparin sodium, dalteparin sodium, and naqu heparin calcium injections. The company also exports its products primarily to the European and American countries. The company was founded in 2000 and is based in Nanjing, the People’s Republic of China.

1/16 Xuefu Road

Nanjing High-Tech Zone

Nanjing,  210061

China

Founded in 2000

618 Employees

Phone:

86 25 8699 0815

Fax:

86 25 8699 0701

Key Executives for Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd does not have any Key Executives recorded.

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd Key Developments

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd Announces Amendment to Articles of Association

Nanjing King-Friend Biochemical Pharmaceutical Co. Ltd. announced amending Articles of Association.

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd Proposes Amendment to Articles of Association

Nanjing King-Friend Biochemical Pharmaceutical Co. Ltd. announced that its first extraordinary general meeting to be held on August 18, 2017 will proposes amendments to the company's articles of association.

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd, Board Meeting, Jul 31, 2017

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd, Board Meeting, Jul 31, 2017. Agenda: To discuss and approve issues including the proposal of increasing registered capital, amending articles of association and handling registration change at industrial and commercial administration authorities; to consider the proposal of replacing self-raised funds invested in advance in investment projects financed by raised funds with raised funds; and to consider the proposal of full text of semi-annual report of 2017 and its abstract.

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd, please visit www.nkf-pharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.